Ledger.Open graph →
SEC Form D · filed September 7, 2023

Tentarix Biotherapeutics, LP

Offering
$35.0M
Sold
$35.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Paul Grayson · La Jolla, CAExec · DirectorStephen F. Demarest · San Diego, CAExecDonald J. Santel · San Diego, CADirectorPaul Kang · La Jolla, CADirectorAllyson F. Tighe · San Diego, CADirectorThomas F. Bumol · San Diego, CADirectorSrinivas Akkaraju · Bothell, WADirectorJerel Davis · Cleveland, OHDirectorMargaret F. Karow · San Diego, CAExecPaul Kang · La Jolla, CADirectorAllyson F. Tighe · San Diego, CADirectorThomas F. Bumol · San Diego, CADirectorSrinivas Akkaraju · SOUTH SAN FRANCISCO, CADirectorPaul Grayson · La Jolla, CAExec · DirectorJerel Davis · Cleveland, OHDirectorMargaret F. Karow · San Diego, CAExecStephen F. Demarest · San Diego, CAExecDonald J. Santel · Brisbane, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗